Variables | Total (n = 329) | Groups based on baseline RDW value and ΔRDW72hr-adm† | P value | |||
---|---|---|---|---|---|---|
Group 1 | Group 2 | Group 3 | Group 4 | |||
(n = 108) | (n = 63) | (n = 121) | (n = 37) | |||
Demographic data | ||||||
Age (years) | 64.4 ± 15.6 | 59.7 ± 17.9 | 67.0 ± 12.1 | 66.3 ± 14.3 | 67.2 ± 15.7 | 0.002 |
Male, n (%) | 161 (48.9%) | 47 (43.5%) | 36 (57.1%) | 56 (46.3%) | 22 (59.5%) | 0.176 |
MAP (mmHg) | 60.0 ± 8.3 | 60.2 ± 8.7 | 60.7 ± 7.7 | 59.7 ± 7.9 | 59.4 ± 9.8 | 0.863 |
BMI (kg/m2) | 23.0 ± 3.9 | 23.3 ± 4.1 | 22.1 ± 4.4 | 23.3 ± 3.4 | 22.7 ± 3.9 | 0.150 |
APACHE II score | 17.5 ± 7.3 | 14.8 ± 6.4 | 19.2 ± 17.3 | 17.3 ± 6.7 | 23.0 ± 7.6 | <0.001 |
SOFA score | 8.1 ± 2.8 | 7.0 ± 2.5 | 8.8 ± 2.7 | 8.1 ± 2.9 | 9.5 ± 3.0 | <0.001 |
Charlson Comorbidity Index | 1.4 ± 1.5 | 1.1 ± 1.3 | 2.0 ± 1.7 | 1.2 ± 1.4 | 1.5 ± 1.5 | 0.001 |
Biochemical data | ||||||
RDW at baseline (%) | 14.0 ± 1.6 | 13.2 ± 0.7 | 16.0 ± 1.3 | 13.0 ± 0.8 | 15.8 ± 1.1 | <0.001 |
RDW at 72 hours (%) | 14.1 ± 1.6 | 13.0 ± 0.7 | 15.6 ± 1.3 | 13.6 ± 0.8 | 16.5 ± 1.2 | <0.001 |
WBC (x 103/mm3) | 13.9 ± 9.3 | 13.0 ± 7.4 | 15.1 ± 12.0 | 14.5 ± 9.8 | 12.2 ± 6.2 | 0.286 |
Hemoglobin (g/dL) | 12.3 ± 2.2 | 12.8 ± 2.1 | 11.5 ± 1.8 | 12.5 ± 2.0 | 11.6 ± 2.7 | <0.001 |
Hematocrit (%) | 36.6 ± 6.2 | 37.7 ± 6.1 | 34.7 ± 5.5 | 37.0 ± 5.9 | 35.3 ± 8.0 | 0.010 |
CRP (mg/dL) | 15.2 ± 11.3 | 13.1 ± 10.3 | 14.4 ± 11.8 | 16.9 ± 11.1 | 16.7 ± 13.1 | 0.054 |
Creatinine (mg/dL) | 2.1 ± 1.8 | 1.7 ± 1.7 | 2.4 ± 2.1 | 2.0 ± 1.5 | 2.6 ± 2.2 | 0.026 |
eGFR (mL/min/1.73 m2) | 54.0 ± 27.7 | 59.0 ± 26.5 | 56.9 ± 29.9 | 49.5 ± 26.5 | 49.5 ± 29.5 | 0.045 |
Albumin (g/dL) | 3.3 ± 0.7 | 3.6 ± 0.6 | 2.9 ± 0.8 | 3.4 ± 0.6 | 2.9 ± 0.8 | <0.001 |
Total cholesterol (mg/dL) | 128.7 ± 43.0 | 138.3 ± 41.9 | 115.1 ± 44.1 | 131.4 ± 39.8 | 114.8 ± 46.3 | 0.001 |
Total bilirubin (mg/dL) | 1.3 ± 1.5 | 1.2 ± 1.1 | 1.3 ± 1.7 | 1.2 ± 1.1 | 1.7 ± 2.7 | 0.224 |
pH | 7.42 ± 0.10 | 7.43 ± 0.08 | 7.41 ± 0.12 | 7.43 ± 0.09 | 7.39 ± 0.09 | 0.113 |
Bicarbonate (mEq/L) | 21.0 ± 5.2 | 21.1 ± 4.9 | 20.8 ± 5.6 | 21.3 ± 5.1 | 20.6 ± 6.1 | 0.094 |
Lactate (mmol/L) | 3.40 ± 2.80 | 3.17 ± 2.64 | 3.77 ± 2.56 | 3.13 ± 2.93 | 4.35 ± 3.00 | 0.065 |
Infection site, n (%) | 0.002 | |||||
Lung (pneumonia) | 80 (24.3%) | 15 (13.9%) | 23 (36.5%) | 24 (19.8%) | 18 (48.6%) | |
Urinary tract | 81 (24.6%) | 30 (27.8%) | 10 (15.9%) | 37 (30.6%) | 4 (10.8%) | |
Intra-abdominal site | 72 (21.9%) | 29 (26.9%) | 10 (15.9%) | 26 (21.5%) | 7 (18.9%) | |
Other | 71 (21.6%) | 28 (25.9%) | 14 (22.2%) | 24 (19.8%) | 5 (13.5%) | |
Multiple sites | 25 (7.6%) | 6 (5.6%) | 6 (9.5%) | 10 (8.3%) | 3 (8.1%) | |
Acute kidney injury, n (%) ‡ | 174 (52.9%) | 49 (45.4%) | 35 (55.6%) | 68 (56.2%) | 22 (59.5%) | 0.284 |
RRT, n (%) | 54 (16.4%) | 6 (5.6%) | 15 (23.8%) | 16 (13.2%) | 17 (45.9%) | <0.001 |
28-day mortality, n (%) | 33 (10.0%) | 2 (1.9%) | 11 (17.5%) | 8 (6.6%) | 12 (32.4%) | <0.001 |
90-day mortality, n (%) | 48 (14.6%) | 2 (1.9%) | 13 (20.6%) | 16 (13.2%) | 17 (45.9%) | <0.001 |
Total length of hospital stay (days) | 19.3 ± 22.8 | 14.3 ± 11.7 | 26.9 ± 22.8 | 16.6 ± 10.8 | 44.2 ± 64.3 | <0.001 |